biocryst pharmaceuticals

Biocryst And 3DP Complement Agreement

BioCryst Pharmaceuticals, Inc. has transferred rights to specific classes of compounds that act as inhibitors of proteins and enzymes in the complement system to 3- Dimensional Pharmaceuticals, Inc. (3DP), a wholly owned subsidiary of Johnson & Johnson. BioCryst will receive an initial payment from 3DP, and will receive royalties on any future sales of complement Read more about Biocryst And 3DP Complement Agreement[…]

boston life sciences

Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff

Boston Life Sciences, Inc. has announced it has entered into an agreement with Codman & Shurtleff, Inc., a Johnson & Johnson subsidiary, related to BLSI’s development of Inosine for stroke. Under the agreement, Codman will supply BLSI with implantable pumps and catheters for BLSI’s preclinical and clinical studies for Inosine, and in exchange, Codman will Read more about Drug Delivery Device Supply Agreement For Boston Life Sciences And Codman & Shurtleff[…]

Photoelectron Announces Strategic Partnership With Cordis

Photoelectron Corporation has signed an exclusive agreement with Cordis Corporation, a Johnson & Johnson Company, to co-develop and co- manufacture a disposable miniature x-ray source and associated technology for the delivery of intravascular radiation therapy to prevent restenosis of coronary arteries following angioplasty and stent procedures. Cordis Corporation is a leader in circulatory disease management. Read more about Photoelectron Announces Strategic Partnership With Cordis[…]

Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss

Johnson & Johnson have announced that obese patients lost over 11 percent of their body weight one year after being treated with the company’s anti-epilepsy drug Topamax.The firm is encouraged to continue developing the medicine as a weight-loss medicine.Topamax is currently approved only for treatment of epilepsy, but the New Brunswick, N.J.-based firm is also Read more about Johnson &Johnson’s Epilepsy Drug Leads To Weight Loss[…]

Shop Dragon Pharma

1-Test Cyp 200

Injectable Anabolic Steroid
Base Substance: Dihydroboldenone Cypionate
Branded by: Dragon Pharma
Amount: 1 X 10 mL vial (200 mg/mL)

Primobolan 100 - Cheap Price

Administration: Injection
Active Component: Methenolone Enanthate
Manufacturer: Dragon Pharmaceutical
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $65.00

Turanabol - Discount Price

Administration: Oral
Primary Constituent: Chlorodehydromethyltestosterone
Manufacturer: Dragon Pharma Labs
Unit: 30 x 100 pastilles (10 mg/tablet)
Price: 30 x $55.00

EQ 300 - Cheap Price

Administration: Injection
Basic Ingredient: Boldenone Undecylenate
Made by: Dragon Pharmaceutical
Unit: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Propionat 100

Injectable Anabolic Steroid
Basic Constituent: Testosterone Propionate
Made by: Dragon Pharma LLC
Package: 1 X 10 ml (100 mg/ml)

Primobolan 100 - Discount Price

Administration: Injection
Basic Substance: Methenolone Enanthate
Produced by: Dragon Pharmaceutical
Unit: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $55.00

TriTren 150 - Bulk Price

Administration: Injection
Principal Chemical Name: Tri Trenbolone
Manufacturer: Dragon Pharma Labs
Package: 10 x 10 mL vial (150 mg/mL)
Price: 10 x $72.00

NPP 150 [10 Vials]

Injectable Steroid for Muscle Growth
Principal Ingredient: Nandrolone Phenylpropionate
Produced by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (150 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total

Cypionat 250

Injectable Steroid for Muscle Growth
Prime Component: Testosterone Cypionate
Made by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (250 mg/mL)

Primobolan 100

Basic Chemical Name: Methenolone Enanthate
Producer: Dragon Pharmaceutical
Unit: 10 x 10 mL vial (100 mg/mL)

EQ 300

Basic Ingredient: Boldenone Undecylenate
Manufacturer: Dragon Pharma
Package: 10 mL vial (300 mg/mL)

Trenbolone 100

Main Ingredient: Trenbolone Acetate
Branded by: Dragon Pharmaceuticals
Package: 10 mL vial (100 mg/mL)